Welcome!

SYS-CON UK Authors: Salvatore Genovese, Jamie Matusow

News Feed Item

Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- 

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.

JDA Software Group Inc.
Levi & Korsinsky is investigating the Board of Directors of JDA Software Group Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to RedPrairie Corp. for $45 per share.

Click here to learn more about the investigation http://zlk.9nl.com/jda-software, or call: 877-363-5972.

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.

For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.   

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.

For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm.  You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

SOURCE Levi & Korsinsky, LLP

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.